Abstract

The Nrf2 (nuclear erythroid 2 p45-related factor-2) signaling pathway is known to play a pivotal role in a variety of oxidative stress-related human disorders. It has been reported recently that the plasma membrane resident protein caveolin-1 (Cav-1) can regulate expression of certain antioxidant enzymes and involves in the pathogenesis of oxidative lung injury, but the detailed molecular mechanisms remain incompletely understood. Here, we demonstrated that Cav-1 inhibited the expression of antioxidant enzymes through direct interaction with Nrf2 and subsequent suppression of its transcriptional activity in lung epithelial Beas-2B cells. Cav-1 deficiency cells exhibited higher levels of antioxidant enzymes and were more resistant to oxidative stress induced cytotoxicity, whereas overexpression of Cav-1 suppressed the induction of these enzymes and further augmented the oxidative cell death. Cav-1 constitutively interacted with Nrf2 in both cytosol and nucleus. Stimulation of 4-hydroxynonenol increased the Cav-1-Nrf2 interaction in cytosol but disrupted their association in the nucleus. Knockdown of Cav-1 also disassociated the interaction between Nrf2 and its cytoplasmic inhibitor Keap1 (Kelch-like ECH-associated protein 1) and increased the Nrf2 transcription activity. Mutation of the resembling Cav-1 binding motif on Nrf2 effectively attenuated their interaction, which exhibited higher transcription activity and induced higher levels of antioxidant enzymes relative to the wild-type control. Altogether, these studies clearly demonstrate that Cav-1 inhibits cellular antioxidant capacity through direct interaction with Nrf2 and subsequent suppression of its activity, thereby implicating in certain oxidative stress-related human pathologies.

Highlights

  • Caveolin-1 regulates cellular antioxidant capacity, but mechanisms remain unknown

  • As we have found that both heme oxygenase (HO)-1 and thioredoxin reductase 1 could be transcriptionally regulated by the same transcription factor Nrf2 [14], we hypothesized that Cav-1 might regulate the expression of these antioxidant enzymes through regulation of Nrf2 activity

  • Epithelial Beas-2B cells were transfected with Cav-1 siRNA and treated with 15 ␮M of 4-HNE, an ␣,␤-unsaturated aldehyde, which has been shown to effectively disrupt the Keap1-Nrf2 complex and to induce expression of antioxidant enzymes at low concentrations without any appreciable cytotoxicity (14, 26 –28)

Read more

Summary

Background

Caveolin-1 regulates cellular antioxidant capacity, but mechanisms remain unknown. Results: Caveolin-1 interacts with Nrf and suppresses its transcriptional activity and down-regulates cellular antioxidant enzymes. Tion of the resembling Cav-1 binding motif on Nrf effectively attenuated their interaction, which exhibited higher transcription activity and induced higher levels of antioxidant enzymes relative to the wild-type control These studies clearly demonstrate that Cav-1 inhibits cellular antioxidant capacity through direct interaction with Nrf and subsequent suppression of its activity, thereby implicating in certain oxidative stress-related human pathologies. Volonte and Galbiati [23] have found that Cav-1 could interact with thioredoxin reductase 1 and suppress its activity, and deletion of Cav-1 by siRNA increased the dimeric expression of thioredoxin reductase 1 These studies suggest that Cav-1 plays an important role in regulation of cellular antioxidant capacity. We demonstrated that Cav-1 interacted with the Keap1-Nrf system and suppressed the transcription activity of Nrf, thereby regulating the expression of cellular antioxidant enzymes such as GCLC and HO-1 and subsequent cellular antioxidant capacity

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call